Keymed Biosciences Inc. (2162.HK)
HKD 33.0
(-1.93%)
HKD 33.0
(-1.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 354.09 Million | 100.06 Million | 110.26 Million | - | - |
| Cost of Revenue | 36.87 Million | 2.58 Million | 17.2 Million | - | - |
| Gross Profit | 317.21 Million | 97.47 Million | 93.06 Million | - | - |
| Operating Expenses | 317.21 Million | 575.74 Million | 442.88 Million | 135.46 Million | 67.2 Million |
| Selling, General and Administrative Expenses | 177 Million | 133.91 Million | 130.38 Million | 8.93 Million | 7.74 Million |
| Research and Development Expenses | 596.28 Million | 507.37 Million | 358.15 Million | 127.4 Million | 64.81 Million |
| Other Expenses | - | -65.54 Million | -45.65 Million | -869 Thousand | -5.35 Million |
| Cost and Expenses | 788.89 Million | 578.32 Million | 460.08 Million | 135.46 Million | 67.2 Million |
| Operating Income | -434.8 Million | -295.37 Million | -3.88 Billion | -804.7 Million | -162.19 Million |
| Interest Expense | 17.25 Million | 8.21 Million | 11.13 Million | 14.3 Million | 5.67 Million |
| Income Tax Expense | 1.59 Million | 4.51 Million | 5.81 Million | 13.88 Million | 5.31 Million |
| Earnings before Tax | -356.18 Million | -303.59 Million | -3.89 Billion | -818.84 Million | -167.51 Million |
| Net Income | -359.35 Million | -308.11 Million | -3.89 Billion | -832.73 Million | -172.82 Million |
| Earnings Per Share Basic | -1.37 | -1.18 | -24.24 | -3.07 | -0.64 |
| Earnings Per Share Diluted | -1.37 | -1.18 | -24.24 | -3.07 | -0.64 |
| Weighted Average Shares Outstanding | 261.36 Million | 261.12 Million | 160.84 Million | 270.99 Million | 270.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 261.36 Million | 261.12 Million | 160.84 Million | 270.99 Million | 270.99 Million |
| Gross Margin | 0.90 | 0.97 | 0.84 | - | - |
| EBIT Margin | -0.76 | -2.59 | -35.01 | - | - |
| Profit Margin | -1.01 | -3.08 | -35.35 | - | - |
| EBITDA | -269.76 Million | -259.25 Million | -3.86 Billion | -785.7 Million | -71.83 Million |
| Earnings Before Tax Margin | -1.23 | -2.95 | -35.20 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 27.34 Million | 27.34 Million | 13.48 Million | 354.09 Million | 13.48 Million | 163.56 Million |
| Cost of Revenue | 1.86 Million | 1.86 Million | 10.93 Million | 36.87 Million | 10.93 Million | 7.5 Million |
| Gross Profit | 25.47 Million | 25.47 Million | 2.55 Million | 317.21 Million | 2.55 Million | 156.05 Million |
| Operating Expenses | 222.11 Million | 222.11 Million | 220.57 Million | 752.01 Million | 223.89 Million | 148.35 Million |
| Selling, General and Administrative Expenses | 56.59 Million | 56.59 Million | 47.31 Million | - | 47.31 Million | 41.18 Million |
| Research and Development Expenses | 165.51 Million | 165.51 Million | 173.26 Million | - | 173.26 Million | 124.87 Million |
| Other Expenses | - | - | - | 1.19 Million | - | - |
| Cost and Expenses | 223.97 Million | 223.97 Million | 231.51 Million | 788.89 Million | 234.82 Million | 155.86 Million |
| Operating Income | -196.63 Million | -196.63 Million | -218.02 Million | -457.43 Million | -218.51 Million | -10.2 Million |
| Interest Expense | - | - | - | 17.25 Million | - | 10.55 Million |
| Income Tax Expense | 3.03 Million | 3.03 Million | 798.5 Thousand | 1.59 Million | 798.5 Thousand | 3.7 Million |
| Earnings before Tax | -165.26 Million | -165.26 Million | -202.16 Million | -356.18 Million | -202.16 Million | 24.07 Million |
| Net Income | -168.37 Million | -168.37 Million | -203.16 Million | -359.35 Million | -203.16 Million | 23.48 Million |
| Earnings Per Share Basic | -0.64 | -0.64 | -0.78 | - | -0.78 | 0.09 |
| Earnings Per Share Diluted | -0.64 | -0.64 | -0.78 | - | -0.78 | 0.09 |
| Weighted Average Shares Outstanding | 261.04 Million | 261.04 Million | 260.91 Million | 261.36 Million | 260.91 Million | 261.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 261.55 Million | 261.55 Million | 261.44 Million | 261.36 Million | 261.44 Million | 265.52 Million |
| Gross Margin | 0.93 | 0.93 | 0.19 | 0.90 | 0.19 | 0.95 |
| EBIT Margin | -6.51 | -6.51 | -14.98 | - | -14.98 | -0.01 |
| Profit Margin | -6.16 | -6.16 | -15.07 | -1.01 | -15.07 | 0.14 |
| EBITDA | -177.89 Million | -177.89 Million | -201.94 Million | - | -201.94 Million | -952.5 Thousand |
| Earnings Before Tax Margin | -7.19 | -7.19 | -16.17 | -1.29 | -16.20 | -0.06 |
UI
1085
LIGT3
9021
MBT
WTBDY